Pankaj Nishikant Surange

Pankaj Nishikant Surange

Active Director Director DIN 07425966
DIN 07425966 First appointment Feb 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Total affiliations 8 Since Feb 2017
Shareholding value •••• Premium profile

About Pankaj Nishikant Surange

Data last updated:

Pankaj Nishikant Surange is a Director at Surange Healthcare (North India) Private Limited (since 2021), Director at Surange Healthcare India Private Limited (since 2020) and Director at Surange Varsity India Private Limited (since 2020), and holds 5 more current directorships. The companies operate in Healthcare, Education and Non-Profit Organizations. The 5 current companies with reported revenue have a combined latest revenue of ₹12.13 Cr; the largest is Surange Healthcare (North India) Private Limited at ₹9.37 Cr (FY 2025).

DIN 07425966
Primary Designation Director
Industry Healthcare
First Appointment 10 Feb 2017
Oldest Company Age 9 yrs
Largest company Surange Healthcare (North India) Private Limited · ₹9.37 Cr (FY 2025)
Combined revenue ₹12.13 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Feb 20212021₹9.37 Cr (FY 2025)Active
Director27 Jun 20202020₹1.64 Cr (FY 2025)Active
Director03 Dec 20202020₹92.2 Lakh (FY 2024)Active
Director23 Jul 20212021₹18.8 Lakh (FY 2024)Active
Capsipain Private Limited U74999DL2017PTC312680
Director10 Feb 20172017₹1.2 Lakh (FY 2021)Active
Director05 Aug 20262026Active
Director29 Jun 20262026Active
My Family First Foundation U85300DL2021NPL385870
Director01 Sep 20212021Active

Directorship timeline

Open interactive timeline →
Surange Varsity India Private Limited
Capsipain Private Limited
Surange Healthcare India Private Limited
Surange Healthcare (North India) Private Limited
Premium access

Shareholding and investment profile for Pankaj Nishikant Surange

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankaj Nishikant Surange

Pankaj Nishikant Surange currently holds 8 directorships: Surange Healthcare (North India) Private Limited (Director, since 17 Feb 2021, revenue ₹9.37 Cr (FY 2025)); Surange Healthcare India Private Limited (Director, since 27 Jun 2020, revenue ₹1.64 Cr (FY 2025)); Surange Varsity India Private Limited (Director, since 03 Dec 2020, revenue ₹92.2 Lakh (FY 2024)); My Family First Healthtech Private Limited (Director, since 23 Jul 2021, revenue ₹18.8 Lakh (FY 2024)); Capsipain Private Limited (Director, since 10 Feb 2017, revenue ₹1.2 Lakh (FY 2021)); and 3 more.

Pankaj Nishikant Surange was first appointed on 10 Feb 2017 as Director at Capsipain Private Limited. The most recent appointment on record is 05 Aug 2026 at Ipsc Healthcare India Private Limited.

The 5 current companies of Pankaj Nishikant Surange that report revenue have a combined latest revenue of ₹12.13 Cr: Surange Healthcare (North India) Private Limited ₹9.37 Cr (FY 2025); Surange Healthcare India Private Limited ₹1.64 Cr (FY 2025); Surange Varsity India Private Limited ₹92.2 Lakh (FY 2024); My Family First Healthtech Private Limited ₹18.8 Lakh (FY 2024); Capsipain Private Limited ₹1.2 Lakh (FY 2021).

The current boards of Pankaj Nishikant Surange's companies include Amit (Surange Healthcare (North India) Private Limited), Harshita Surange (Surange Healthcare (North India) Private Limited), Mohit Malik (Surange Healthcare (North India) Private Limited), Palak Bhavinbhai Mehta (Capsipain Private Limited), Swati Bhat (Ipsc Healthcare India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available